Magnesium in PDB 5sfv: Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide, PDB code: 5sfv
was solved by
C.Joseph,
J.U.Peters,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.58 /
2.41
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
134.925,
134.925,
234.826,
90,
90,
120
|
R / Rfree (%)
|
18.5 /
24.9
|
Other elements in 5sfv:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide
(pdb code 5sfv). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 4 binding sites of Magnesium where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide, PDB code: 5sfv:
Jump to Magnesium binding site number:
1;
2;
3;
4;
Magnesium binding site 1 out
of 4 in 5sfv
Go back to
Magnesium Binding Sites List in 5sfv
Magnesium binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg802
b:20.7
occ:1.00
|
O
|
A:HOH909
|
2.0
|
19.1
|
1.0
|
OD1
|
A:ASP564
|
2.0
|
23.3
|
1.0
|
O
|
A:HOH930
|
2.0
|
15.0
|
1.0
|
O
|
A:HOH980
|
2.1
|
18.8
|
1.0
|
O
|
A:HOH954
|
2.2
|
26.2
|
1.0
|
O
|
A:HOH939
|
2.2
|
19.9
|
1.0
|
CG
|
A:ASP564
|
2.9
|
21.7
|
1.0
|
OD2
|
A:ASP564
|
3.2
|
21.2
|
1.0
|
O
|
A:HOH966
|
3.7
|
29.3
|
1.0
|
ZN
|
A:ZN801
|
3.8
|
25.1
|
1.0
|
NE2
|
A:HIS595
|
4.0
|
22.8
|
1.0
|
O
|
A:HOH982
|
4.0
|
27.6
|
1.0
|
CD2
|
A:HIS567
|
4.0
|
28.2
|
1.0
|
OE2
|
A:GLU592
|
4.3
|
25.7
|
1.0
|
NE2
|
A:HIS567
|
4.3
|
28.6
|
1.0
|
CB
|
A:ASP564
|
4.3
|
20.2
|
1.0
|
CD2
|
A:HIS563
|
4.3
|
18.2
|
1.0
|
O
|
A:HOH997
|
4.3
|
35.8
|
1.0
|
CD2
|
A:HIS595
|
4.4
|
22.9
|
1.0
|
O
|
A:HIS563
|
4.4
|
23.5
|
1.0
|
OG1
|
A:THR633
|
4.5
|
25.3
|
1.0
|
CD2
|
A:HIS525
|
4.5
|
26.1
|
1.0
|
NE2
|
A:HIS525
|
4.5
|
25.7
|
1.0
|
OD2
|
A:ASP674
|
4.6
|
27.0
|
1.0
|
NE2
|
A:HIS563
|
4.6
|
17.2
|
1.0
|
CA
|
A:ASP564
|
4.7
|
21.4
|
1.0
|
O
|
A:THR633
|
4.7
|
22.8
|
1.0
|
CG
|
A:GLU592
|
4.9
|
24.6
|
1.0
|
CB
|
A:THR633
|
4.9
|
22.0
|
1.0
|
O
|
A:HOH998
|
5.0
|
32.3
|
1.0
|
|
Magnesium binding site 2 out
of 4 in 5sfv
Go back to
Magnesium Binding Sites List in 5sfv
Magnesium binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg802
b:12.8
occ:1.00
|
O
|
B:HOH907
|
1.9
|
9.5
|
1.0
|
O
|
B:HOH927
|
1.9
|
10.2
|
1.0
|
O
|
B:HOH921
|
2.0
|
12.8
|
1.0
|
O
|
B:HOH989
|
2.1
|
12.7
|
1.0
|
O
|
B:HOH930
|
2.2
|
10.6
|
1.0
|
OD1
|
B:ASP564
|
2.2
|
20.5
|
1.0
|
CG
|
B:ASP564
|
3.3
|
20.6
|
1.0
|
OE2
|
B:GLU592
|
3.6
|
20.8
|
1.0
|
OD2
|
B:ASP564
|
3.6
|
19.5
|
1.0
|
O
|
B:HOH1016
|
3.9
|
42.4
|
1.0
|
O
|
B:HOH956
|
4.0
|
22.4
|
1.0
|
NE2
|
B:HIS595
|
4.0
|
22.6
|
1.0
|
OG1
|
B:THR633
|
4.1
|
19.3
|
1.0
|
ZN
|
B:ZN801
|
4.1
|
26.1
|
1.0
|
O
|
B:HIS563
|
4.2
|
21.8
|
1.0
|
CD2
|
B:HIS595
|
4.3
|
22.2
|
1.0
|
CD2
|
B:HIS567
|
4.3
|
19.0
|
1.0
|
CD2
|
B:HIS563
|
4.3
|
15.5
|
1.0
|
OD2
|
B:ASP674
|
4.4
|
29.5
|
1.0
|
NE2
|
B:HIS567
|
4.4
|
19.5
|
1.0
|
O
|
B:THR633
|
4.4
|
18.8
|
1.0
|
CD
|
B:GLU592
|
4.5
|
22.7
|
1.0
|
CG
|
B:GLU592
|
4.5
|
22.7
|
1.0
|
O
|
B:HOH959
|
4.5
|
32.6
|
1.0
|
CB
|
B:THR633
|
4.6
|
19.3
|
1.0
|
CB
|
B:ASP564
|
4.6
|
21.5
|
1.0
|
NE2
|
B:HIS563
|
4.7
|
16.1
|
1.0
|
NE2
|
B:HIS525
|
4.8
|
20.0
|
1.0
|
CD2
|
B:HIS525
|
4.9
|
22.7
|
1.0
|
CA
|
B:ASP564
|
4.9
|
20.5
|
1.0
|
O
|
B:HOH997
|
5.0
|
27.1
|
1.0
|
C
|
B:THR633
|
5.0
|
17.9
|
1.0
|
|
Magnesium binding site 3 out
of 4 in 5sfv
Go back to
Magnesium Binding Sites List in 5sfv
Magnesium binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg802
b:22.4
occ:1.00
|
O
|
C:HOH996
|
1.9
|
20.1
|
1.0
|
OD1
|
C:ASP564
|
2.1
|
25.6
|
1.0
|
O
|
C:HOH921
|
2.1
|
22.3
|
1.0
|
O
|
C:HOH942
|
2.1
|
21.0
|
1.0
|
O
|
C:HOH946
|
2.2
|
20.4
|
1.0
|
O
|
C:HOH960
|
2.2
|
16.9
|
1.0
|
CG
|
C:ASP564
|
3.1
|
24.7
|
1.0
|
OD2
|
C:ASP564
|
3.5
|
27.2
|
1.0
|
ZN
|
C:ZN801
|
3.9
|
31.2
|
1.0
|
NE2
|
C:HIS595
|
3.9
|
26.7
|
1.0
|
CD2
|
C:HIS567
|
4.1
|
26.4
|
1.0
|
OE2
|
C:GLU592
|
4.1
|
24.5
|
1.0
|
CD2
|
C:HIS563
|
4.2
|
17.8
|
1.0
|
NE2
|
C:HIS567
|
4.2
|
27.9
|
1.0
|
O
|
C:HIS563
|
4.3
|
22.8
|
1.0
|
CD2
|
C:HIS595
|
4.4
|
27.2
|
1.0
|
O
|
C:HOH958
|
4.4
|
32.8
|
1.0
|
OG1
|
C:THR633
|
4.4
|
26.6
|
1.0
|
CB
|
C:ASP564
|
4.5
|
23.7
|
1.0
|
NE2
|
C:HIS563
|
4.5
|
16.0
|
1.0
|
OD2
|
C:ASP674
|
4.5
|
27.9
|
1.0
|
O
|
C:THR633
|
4.6
|
28.5
|
1.0
|
CD2
|
C:HIS525
|
4.6
|
32.9
|
1.0
|
NE2
|
C:HIS525
|
4.7
|
35.0
|
1.0
|
CB
|
C:THR633
|
4.8
|
27.0
|
1.0
|
CA
|
C:ASP564
|
4.8
|
22.5
|
1.0
|
CG
|
C:GLU592
|
4.9
|
23.8
|
1.0
|
CD
|
C:GLU592
|
5.0
|
24.8
|
1.0
|
CE1
|
C:HIS595
|
5.0
|
28.8
|
1.0
|
O
|
C:HOH1014
|
5.0
|
49.0
|
1.0
|
|
Magnesium binding site 4 out
of 4 in 5sfv
Go back to
Magnesium Binding Sites List in 5sfv
Magnesium binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4- (Azetidine-1-Carbonyl)-N-(1-Cyclopentylpyrazol-3-Yl)-2- Methylpyrazole-3-Carboxamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg802
b:25.9
occ:1.00
|
O
|
D:HOH956
|
2.0
|
33.8
|
1.0
|
OD1
|
D:ASP564
|
2.1
|
30.8
|
1.0
|
O
|
D:HOH923
|
2.1
|
24.0
|
1.0
|
O
|
D:HOH924
|
2.1
|
21.4
|
1.0
|
O
|
D:HOH943
|
2.2
|
18.9
|
1.0
|
O
|
D:HOH907
|
2.2
|
26.8
|
1.0
|
CG
|
D:ASP564
|
3.0
|
30.8
|
1.0
|
OD2
|
D:ASP564
|
3.1
|
32.3
|
1.0
|
ZN
|
D:ZN801
|
3.6
|
36.5
|
1.0
|
O
|
D:HOH939
|
3.8
|
27.8
|
1.0
|
CD2
|
D:HIS563
|
4.2
|
27.1
|
1.0
|
O
|
D:HOH951
|
4.2
|
39.7
|
1.0
|
OE2
|
D:GLU592
|
4.2
|
33.0
|
1.0
|
OG1
|
D:THR633
|
4.3
|
32.5
|
1.0
|
NE2
|
D:HIS595
|
4.3
|
32.6
|
1.0
|
CD2
|
D:HIS567
|
4.3
|
33.3
|
1.0
|
CB
|
D:ASP564
|
4.4
|
29.8
|
1.0
|
O
|
D:HIS563
|
4.4
|
27.6
|
1.0
|
CD2
|
D:HIS525
|
4.4
|
34.1
|
1.0
|
NE2
|
D:HIS567
|
4.4
|
35.5
|
1.0
|
NE2
|
D:HIS525
|
4.4
|
31.3
|
1.0
|
O
|
D:THR633
|
4.4
|
35.1
|
1.0
|
OD2
|
D:ASP674
|
4.4
|
34.2
|
1.0
|
NE2
|
D:HIS563
|
4.5
|
27.2
|
1.0
|
CD2
|
D:HIS595
|
4.7
|
32.6
|
1.0
|
CA
|
D:ASP564
|
4.8
|
32.4
|
1.0
|
CB
|
D:THR633
|
4.8
|
32.1
|
1.0
|
OD1
|
D:ASP674
|
4.9
|
34.1
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Sep 30 03:40:50 2024
|